BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6158975)

  • 1. The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model.
    Raghavan D; Gibbs J; Nogueira Costa R; Kohn J; Orr AH; Barrett A; Peckham MJ
    Br J Cancer Suppl; 1980 Apr; 4():191-4. PubMed ID: 6158975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase].
    Schwarz HP; Susani M; Kratzik C; Studler G; Krisch K; Aiginger P
    Wien Klin Wochenschr; 1984 Mar; 96(6):230-4. PubMed ID: 6204462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germ cell tumours of the testis.
    Risdon RA
    J Pathol; 1983 Nov; 141(3):355-61. PubMed ID: 6198501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-fetoprotein (AFP) and human chorionic gonadotropin (HCG) in testicular germ cell tumours. A comparison of histologic and serologic occurrence of tumour markers.
    Jacobsen GK
    Acta Pathol Microbiol Immunol Scand A; 1983 May; 91(3):183-90. PubMed ID: 6190351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
    Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
    Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers].
    Yamauchi M; Yoshigoe F; Mera F; Ogura K; Kameda H; Nakada J; Takasaka S; Machida T; Fukunaga M
    Gan No Rinsho; 1983 Apr; 29(4):A-22, 349-52. PubMed ID: 6190021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence and prognostic significance of trophoblastic proteins in testicular teratoma.
    Masters JR; Parkinson MC; Miller ID; Horne CH
    Diagn Histopathol; 1983; 6(3-4):247-52. PubMed ID: 6676077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers and pathology of testicular tumors.
    Mostofi FK
    Prog Clin Biol Res; 1984; 153():69-87. PubMed ID: 6206511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of radioimmunoassay of human chorionic gonadotropin and alpha fetoprotein in nonseminomatous germ cell tumors of the testis.
    Kausitz J; Hupka S; Cerný V; Bohunický L; Korec S
    Neoplasma; 1980; 27(3):321-7. PubMed ID: 6161314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistological evaluation of AFP and hCG in germ cell tumors].
    Kimura N; Namiki T; Wada T; Kuwabara K; Morizuka T; Sasano N
    Gan No Rinsho; 1982; 28(1):34-42. PubMed ID: 6190018
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistological localization of AFP and HCG in uniformly classified testis tumors.
    Wittekind C; Wichmann T; Von Kleist S
    Anticancer Res; 1983; 3(5):327-30. PubMed ID: 6197005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotrophin and alpha-fetoprotein in testicular germ cell tumours: a retrospective immunohistochemical study.
    Bosman FT; Giard RW; Nieuwenhuijen Kruseman AC; Knijnenburg G; Spaander PJ
    Histopathology; 1980 Nov; 4(6):673-84. PubMed ID: 6160088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of cell lines of human germinal tumors].
    Fujino H; Watabe H
    Hokkaido Igaku Zasshi; 1991 Sep; 66(5):639-46. PubMed ID: 1720411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor marker in urology].
    Shimazaki J; Ito H; Miyauchi T; Maruoka M; Isaka S; Masukagami T; Ando K
    Gan No Rinsho; 1983 May; 29(6):684-92. PubMed ID: 6192269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual bilateral primary tumour of the testis.
    Warmenhoven PG; Groot G
    Neth J Surg; 1983 Jul; 35(3):106-8. PubMed ID: 6193459
    [No Abstract]   [Full Text] [Related]  

  • 18. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
    Behrendt H; Ringert RH; Pfeiffer R; Homann W; Hartung R
    Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathology of testicular germ cell tumors].
    Morinaga S; Sasano N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
    Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.